Visa Wins China Approval 💳 Alibaba AI Books Flights 🧠 400km/h Trains Edge Closer 🚄

2026-10-19 | subscribe | homepage

Welcome back to China Insights Weekly. Here are some of the key highlights for this week’s edition:

• Chinese shipyards win 90% of container-ship orders, including all 83 ultra-large container ships

• NAND shipment share reaches 17%, as YMTC prepares to enter DRAM

• Exports jump 36.3%, with a USD 938.1B nine-month surplus

• Shanghai drug research expands, Boehringer targets broader early-stage participation

Last week’s poll: 2 of 4 respondents regularly use Chinese AI at work; 2 have not started yet.

🚀 Headlines

Visa wins approval to set up China's first wholly foreign-owned bank card clearing firm (link)

Visa has won preliminary approval from the People’s Bank of China to establish the country’s first wholly foreign-owned bank card clearing institution. This is a step toward processing domestic transactions independently of China UnionPay once final approval is secured. The San Francisco-based payments giant must complete preparations within one year before seeking final clearance from the PBOC and the National Financial Regulatory Administration. Visa is preparing to become the third international card network operating in China’s domestic clearing market, after American Express in 2020 and Mastercard in 2023, but unlike those rivals, which operate through joint ventures, Visa plans to operate through a wholly owned entity rather than a local joint venture. UnionPay held a monopoly on bank card clearing from its founding in 2002 until China began opening the sector in 2015.

Boehringer Ingelheim opens R&D center in Shanghai, putting China at the center of early-stage R&D (link)

Boehringer Ingelheim announced the opening of a new China R&D Center in Shanghai’s Zhangjiang Science City on October 12, with plans to raise Chinese participation in its early-stage R&D projects to 100%. China already participates in all of the German drugmaker’s global pivotal trials and more than 70% of early-stage clinical research, helping drive global debuts or simultaneous approvals of innovative drugs. The new center integrates discovery, early development, and translational research, with a dedicated Early Medicine team and an External Innovation unit to deepen local partnerships and in-licensing. China approved three Boehringer drugs and five indications in two years; under its “China Strategy 2035”, the firm targets nearly 20 regulatory approvals by 2030.

Alibaba enters personal agent race with Qwen Go! (link)

A fierce race to build the personal AI agent is underway, and Chinese tech giants are moving fast. Alibaba launched “Qwen Go!” on October 13, a limited-invitation personal assistant built on its Qwen 3.8 models, while ByteDance is internally testing “Spell” for Doubao and Tencent is running two parallel projects. Qwen Go! can autonomously execute everyday tasks including booking restaurant tables and flight tickets, submitting job applications, filing and negotiating compensation claims, booking sports venues, arranging car maintenance, and comparing online prices. Access is rolling out in phases, with no date set for full availability. Meanwhile, Meta’s Muse, launched with the Muse Wonder series, prioritizes continuous context through features like Active Memory and Active Focus. The AI arms race is moving beyond answering questions to carrying out tasks, turning the personal assistant from a novelty into a genuine utility.

YMTC captures record 17% of global NAND market as it pushes into DRAM (link)

YMTC has rapidly expanded its global footprint in NAND flash memory, capturing a record 17% share of global NAND shipments in the second quarter of 2026, an increase from 13% a year earlier. The Wuhan-based chipmaker is broadening its portfolio beyond NAND, with enterprise storage drives projected to approach 39% of its revenue by 2028. It is also leveraging its proprietary wafer-bonding technology to enter the DRAM market and develop next-generation high-speed memory. This diversification positions YMTC as a comprehensive memory powerhouse. Building on this momentum, the company has now filed for an IPO on Shanghai’s STAR Market.

China’s plan to make the yuan a global currency enters a faster phase (link)

China's campaign to internationalise the yuan is accelerating beyond trade settlement into financing, investment and reserves. Beijing is broadening offshore products, with plans to increase the scale and frequency of government bond issuance in Hong Kong. Hong Kong authorities are studying short-term yuan debt instruments and plan to launch a redesigned yuan-denominated gold futures contract. Authorities are also expanding derivatives links and introduced government bond futures in Hong Kong in August. It is widening access to panda and dim sum bonds. Cross-border clearing is scaling fast: CIPS, China's system for cross-border renminbi clearing and settlement, handled RMB 180.2 trillion (USD 26.9 trillion) in 2025, with annual transaction value nearly quadrupling over a decade. Analysts expect the next policy focus to be accelerating renminbi asset markets, though attracting foreign investors seeking diversification remains the main hurdle.